tetano
Editor, Senior Moderator
Clin Chest Med
. 2023 Jun;44(2):335-346.
doi: 10.1016/j.ccm.2022.11.016. Epub 2022 Nov 29.
The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned
Madhavi Parekh[SUP] 1 [/SUP], Darryl Abrams[SUP] 2 [/SUP], Cara Agerstrand[SUP] 2 [/SUP], Jenelle Badulak[SUP] 3 [/SUP], Amy Dzierba[SUP] 4 [/SUP], Peta M A Alexander[SUP] 5 [/SUP], Susanna Price[SUP] 6 [/SUP], Eddy Fan[SUP] 7 [/SUP], Dana Mullin[SUP] 8 [/SUP], Rodrigo Diaz[SUP] 9 [/SUP], Carol Hodgson[SUP] 10 [/SUP], Daniel Brodie[SUP] 2 [/SUP]
Affiliations
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has seen an increase in global cases of severe acute respiratory distress syndrome (ARDS), with a concomitant increased demand for extracorporeal membrane oxygenation (ECMO). Outcomes of patients with severe ARDS due to COVID-19 infection receiving ECMO support are evolving. The need for surge capacity, practical and ethical limitations on implementing ECMO, and the prolonged duration of ECMO support in patients with COVID-19-related ARDS has revealed limitations in organization and resource utilization. Coordination of efforts at multiple levels, from research to implementation, resulted in numerous innovations in the delivery of ECMO.
Keywords: ARDS; Acute respiratory distress syndrome; COVID-19; ECMO; Respiratory failure.
. 2023 Jun;44(2):335-346.
doi: 10.1016/j.ccm.2022.11.016. Epub 2022 Nov 29.
The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned
Madhavi Parekh[SUP] 1 [/SUP], Darryl Abrams[SUP] 2 [/SUP], Cara Agerstrand[SUP] 2 [/SUP], Jenelle Badulak[SUP] 3 [/SUP], Amy Dzierba[SUP] 4 [/SUP], Peta M A Alexander[SUP] 5 [/SUP], Susanna Price[SUP] 6 [/SUP], Eddy Fan[SUP] 7 [/SUP], Dana Mullin[SUP] 8 [/SUP], Rodrigo Diaz[SUP] 9 [/SUP], Carol Hodgson[SUP] 10 [/SUP], Daniel Brodie[SUP] 2 [/SUP]
Affiliations
- PMID: 37085223
- PMCID: PMC9705197
- DOI: 10.1016/j.ccm.2022.11.016
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has seen an increase in global cases of severe acute respiratory distress syndrome (ARDS), with a concomitant increased demand for extracorporeal membrane oxygenation (ECMO). Outcomes of patients with severe ARDS due to COVID-19 infection receiving ECMO support are evolving. The need for surge capacity, practical and ethical limitations on implementing ECMO, and the prolonged duration of ECMO support in patients with COVID-19-related ARDS has revealed limitations in organization and resource utilization. Coordination of efforts at multiple levels, from research to implementation, resulted in numerous innovations in the delivery of ECMO.
Keywords: ARDS; Acute respiratory distress syndrome; COVID-19; ECMO; Respiratory failure.